Biosimilars, Switzerland and more; we interview Anne Marie de Jonge-Schuermans from the Swiss Biotech Association.

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

How to choose equipment for oligonucleotide processes and other valuable tips for optimization.

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

Here’s how paper is weighing down the future of advanced therapies.

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Biological engineering project featuring GSK seeks to use food by-products to create antimicrobials.

We ask about the story behind Nanoform and what nanotechnology could do for drug formulation.

The pharmaceutical trade show CPhI North America 2024 starts in Philadelphia. Here’s The Medicine Maker’s guide to day three.

CPhI North America continues. Here’s our must-see highlights of day 2 at the show.